# 1203
The tour de force by Maryn McKenna on the CIDRAP website; her 7-part series on the pandemic vaccine puzzle, continues tonight with part III. I won't post anything more than the tantalizing opening paragraph.
Follow the link, and read the entire article. It is worth the time.
THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges
Maryn McKenna
Contributing Writer
Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame. Part 2 discussed the huge gap between current global vaccine production capacity and the likely demand for vaccine in the event of a pandemic.
Oct 29, 2007 (CIDRAP News) – Many of the difficulties facing achievement of a pandemic influenza vaccine could not have been anticipated before the pandemic threat arose: They are intrinsic to the H5N1 virus itself.
